Evenflo Company, Inc.
The Evenflo MDL was centralized in June 2020 to coordinate claims alleging that the company marketed certain child booster seats as safe for children as light as 30 pounds and represented that the products had been tested for side-impact protection, when the underlying testing did not reflect real-world crash conditions in the way consumers were led to believe. With 28 actions pending, this has remained a small, stable docket rather than one that has grown into a large mass-personal-injury litigation.
What distinguishes this docket structurally from most other entries in the products-liability category is that its core claims are consumer-protection and marketing-practices claims rather than claims tied to confirmed bodily injury from product failure. The central dispute is about whether the company's safety and testing representations were accurate and adequately supported, not about a defined injury mechanism affecting a large population of product users. That reframes the relevant resolution-risk drivers: rather than general-causation or medical-injury proof, this docket turns on consumer-protection statutory elements, the adequacy of the underlying safety testing, and class-certification-adjacent questions about whether the claims can be resolved on a common basis across purchasers.
Because the claims here are economic and marketing-based rather than injury-based, the docket's duration and resolution path more closely resembles the dynamics of a consumer sales-practices or false-advertising dispute than a personal-injury mass tort, even though it is filed under the products-liability docket category.
Criterica Intelligence treats this kind of marketing-and-sales-practices docket as a distinct structural category from injury-driven mass torts, since the operative legal and evidentiary questions — testing adequacy, representation accuracy, and common proof across a purchaser class — differ meaningfully from a docket organized around a defined physical-injury mechanism, and the platform's structural reads reflect that distinction across the MDL landscape.
It consolidates claims that Evenflo marketed certain child booster seats as tested and safe for side-impact protection down to 30 pounds, when the underlying testing allegedly did not reflect real-world crash conditions as represented to consumers.
The claims here are consumer-protection and marketing-practices claims focused on the accuracy of safety representations, not claims tied to a confirmed injury from product failure, which shifts the resolution-risk drivers toward testing adequacy and common proof rather than medical causation.
It proceeds toward trial on the consumer-protection and marketing-representation claims, focused on whether the company's safety-testing claims were adequately supported, rather than on a personal-injury causation question.
The claims are grounded in a specific set of marketing representations rather than a broad injury mechanism affecting a large population of product users, which has kept the consolidated claims population limited.
Statistics shown reflect historical or illustrative model outputs derived from real case data. They are not predictions or guarantees of any individual outcome. Litigation results depend on facts, jurisdiction, judge, and counsel, and vary case by case. Model accuracy is subject to selection effects and changing legal dynamics.